Calando Pharmaceuticals Inc. was incorporated to pursue the development of proprietary technology licensed from California Institute of Technology.

Calando Pharmaceuticals is headquartered in Pasadena, California.

Calando Pharmaceuticals is a majority-owned subsidiary of Arrowhead Research Corporation.

Investor relations questions should be directed to:

Thomas Schluep
Calando Pharmaceuticals Inc.
c/o Arrowhead Research Corp.
201 S. Lake Ave, Suite 703
Pasadena, CA 91101
626.304.3400
tschluep@calandopharma.com